健脾和胃法治疗胃癌手术后的临床疗效

Clinical efficacy of Jianpi Hewei therapy following gastric cancer surgery

目的:探讨健脾和胃法治疗胃癌手术后的临床疗效。方法:以60例胃癌术后患者为研究对象,随机均分为治疗组和对照组,每组30例。对照组常规西医治疗,采取FLE化疗方案治疗,静脉滴注依托泊苷100mg和甲酰四氢叶酸钙,静脉滴注750mg氟尿嘧啶。治疗组在对照组治疗的基础上加以中药健脾和胃法治疗。比较两组患者治疗后临床症状改善情况。结果:治疗组患者完全缓解17例,部分缓解10例,无变化2例,进展1例,有效率为96.67%;对照组患者完全缓解9例,部分缓解15例,无变化2例,进展4例,有效率为86.67%。治疗组总有效率高于对照组,两种治疗方法差异有统计学意义(P<0.05)。结论:运用中医辨证施治理论观念,采用健脾和胃法治疗胃癌手术后患者效果显著,值得临床推广。

Objective： To investigate the clinical efficacy of Jianpi Hewei therapy Ibllowing gastric cancer surgery. Methods： 60 gastric cancer patients were randomly divided into treatment group and control group, 30 cases in each. Control group for conventional Western medicine, took FLE chemotherapy treatment, intravenous infusion and etoposide 100mg calcium leucovorin, fluorouracil 750mg intravenous infusion. Treatment group accepted Jianpi Hewei therapy plus TCM decoction more than the control group. Results： 17 patients with complete remission, partial remission in 10 cases, no change in 2 cases, progress in 1 case, the effective rate was 96.67%; in the control group, 9 cases patients with complete remission, partial remission in 15 cases, no change in 2 cases, progress in 4 cases, the effective rate was 86.67%. There was higher total efficiency in the treatment group, statistically significant difference （P〈0.05）. Conclusion： Theoretical concepts of TCM syndrome differentiation, Jianpi Hewei therapy following gastric surgery treatment achieved significant results, worthy of promotion.